The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Immunoregulation of a viral model of multiple sclerosis using the synthetic cannabinoid R(+)WIN55,212
Open accessAbstract
Theiler murine encephalomyelitis virus-induced demyelinating disease (TMEV-IDD) is a mouse model of chronic-progressive multiple sclerosis (MS) characterized by Th1-mediated CNS demyelination and spastic hindlimb paralysis. Existing MS therapies reduce relapse rates in 30% of relapsing-remitting MS patients, but are ineffective in chronic-progressive disease, and their effects on disability progression are unclear. Experimental studies demonstrate cannabinoids are useful for symptomatic treatment of spasticity and tremor in chronic-relapsing experimental autoimmune encephalomyelitis. Cannabinoids, however, have reported immunosuppressive properties. We show that the cannabinoid receptor agonist, R+WIN55,212, ameliorates progression of clinical disease symptoms in mice with preexisting TMEV-IDD. Amelioration of clinical disease is associated with downregulation of both virus and myelin epitope-specific Th1 effector functions (delayed-type hypersensitivity and IFN-gamma production) and the inhibition of CNS mRNA expression coding for the proinflammatory cytokines, TNF-alpha, IL1-beta, and IL-6. Clinical trials investigating the therapeutic potential of cannabinoids for the symptomatic treatment of MS are ongoing, and this study demonstrates that they may also have potent immunoregulatory properties.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular characterization of a peripheral receptor for cannabinoids
Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092
Determination and characterization of a cannabinoid receptor in rat brain
Devane, W. A., Dysarz, F. A., Johnson, M. R., Melvin, L. S., & Howlett, A. C. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09876-1 · Cited by 2,443
Cannabidiol and (−)Δ 9 -tetrahydrocannabinol are neuroprotective antioxidants
Hampson, A. J., Grimaldi, M., Axelrod, J., & Wink, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.8268 · Cited by 850
Epidemiologic evidence for multiple sclerosis as an infection
Kurtzke, J. F. (1993) · Clinical Microbiology Reviews · doi:10.1128/cmr.6.4.382 · Cited by 472
Agurell, S., Halldin, M., Lindgren, J. E., Ohlsson, A., Widman, M., Gillespie, H., & Hollister, L. (1986) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06861-9 · Cited by 406
Research works printed but not linked: 53
- 10.1038/346183a0 · DOI · Paper page
- Goodin, 2002, Neurology., 58, 169, 10.1212/WNL.58.2.169 · DOI · Paper page
- Devane, 1988, Mol. Pharmacol., 34, 605
- 10.1111/j.1432-1033.1995.tb20780.x · DOI · Paper page
- 10.1016/S0167-5699(98)01300-0 · DOI · Paper page
- 10.2165/00023210-200317030-00004 · DOI · Paper page
- Baker, 2001, FASEB J., 15, 300, 10.1096/fj.00-0399fje · DOI · Paper page
- 10.1038/35003583 · DOI · Paper page
- 10.1089/088282401753266756 · DOI
- Pevear, 1987, J. Virol., 61, 1507, 10.1128/JVI.61.5.1507-1516.1987 · DOI · Paper page
- Lipton, 1975, Infect. Immun., 11, 1147, 10.1128/IAI.11.5.1147-1155.1975 · DOI · Paper page
- Miller, 1990, Semin. Virol., 1, 263
- Karpus, 1995, J. Immunol., 155, 947, 10.4049/jimmunol.155.2.947 · DOI
- 10.1038/nm1097-1133 · DOI · Paper page
- Croxford, 1998, J. Immunol., 160, 5181, 10.4049/jimmunol.160.10.5181 · DOI
- Croxford, 2000, J. Immunol., 164, 2776, 10.4049/jimmunol.164.5.2776 · DOI
- Croxford, 2001, J. Immunol., 166, 4124, 10.4049/jimmunol.166.6.4124 · DOI
- Olson, 2002, J. Immunol., 169, 2719, 10.4049/jimmunol.169.5.2719 · DOI
- Begolka, 1998, J. Immunol., 161, 4437, 10.4049/jimmunol.161.8.4437 · DOI · Paper page
- Killestein, 2002, Neurology., 58, 1404, 10.1212/WNL.58.9.1404 · DOI · Paper page
- Jacobs, 1991, J. Immunol., 146, 2983, 10.4049/jimmunol.146.9.2983 · DOI · Paper page
- Samoilova, 1998, J. Immunol., 161, 6480, 10.4049/jimmunol.161.12.6480 · DOI · Paper page
- 10.1002/ana.410300510 · DOI · Paper page
- 10.1002/(SICI)1097-4547(19960815)45:4<364::AID-JNR5>3.0.CO;2-7 · doi:10.1002/(sici)1097-4547(19960815)45:4<364::aid-jnr5>3.0.co;2-7
- 10.1046/j.1432-1033.2002.03078.x · DOI · Paper page
- 10.1016/S0165-5728(02)00370-3 · DOI · Paper page
- 10.1016/S0014-5793(98)00851-5 · DOI
- Molina-Holgado, 1997, Neuroreport., 8, 1929, 10.1097/00001756-199705260-00027 · DOI
- 10.1073/pnas.230436397 · DOI · Paper page
- Newton, 1994, Infect. Immun., 62, 4015, 10.1128/IAI.62.9.4015-4020.1994 · DOI
- Rowell, 1999, J. Immunol., 162, 1624, 10.4049/jimmunol.162.3.1624 · DOI
- Strle, 2001, Crit Rev. Immunol., 21, 427, 10.1615/CritRevImmunol.v21.i5.20 · DOI · Paper page
- 10.1159/000126646 · DOI · Paper page
- 10.1016/S0165-5728(97)00226-9 · DOI · Paper page
- 10.1016/S0024-3205(99)00286-6 · DOI
- 10.1016/S0165-5728(00)00349-0 · DOI
- Cabral, 1986, Proc. Soc. Exp. Biol. Med., 181, 305, 10.3181/00379727-181-42258 · DOI
- 10.1128/JVI.75.16.7420-7428.2001 · doi:10.1128/jvi.75.16.7420-7428.2001
- 10.1016/0162-3109(94)90056-6 · DOI
- 10.1016/0165-5728(89)90075-1 · DOI · Paper page
- 10.1016/S0165-5728(99)00149-6 · DOI
- 10.1073/pnas.160105897 · DOI · Paper page
- Ahmed, 2002, Am. J. Pathol., 161, 1577, 10.1016/S0002-9440(10)64436-7 · DOI
- 10.1084/jem.193.1.111 · DOI
- Molina-Holgado, 2002, J. Neurosci., 22, 9742, 10.1523/JNEUROSCI.22-22-09742.2002 · DOI · Paper page
- Werner, 2000, J. Neural Transm. Suppl., 60, 375
- 10.1038/sj.bjp.0701915 · DOI · Paper page
- 10.1074/jbc.272.35.22330 · DOI · Paper page
- 10.1002/syn.1075 · DOI
- 10.1016/S0014-2999(02)01369-9 · DOI
- Agurell, 1986, Pharmacol. Rev., 38, 21
- McPartland, 1999, Altern. Ther. Health Med., 5, 57
- Chan, 1987, Pediatrics., 79, 946
Cited by
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
Pacher, P., Bátkai, S., & Kunos, G. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.2 · Cited by 2,077
Cannabinoid-based drugs as anti-inflammatory therapeutics
Klein, T. W. (2005) · Nature Reviews Immunology · doi:10.1038/nri1602 · Cited by 728
Synthetic cannabinoids: Epidemiology, pharmacodynamics, and clinical implications
Castaneto, M. S., Gorelick, D. A., Desrosiers, N. A., Hartman, R. L., Pirard, S., & Huestis, M. A. (2014) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2014.08.005 · Cited by 709
Yiangou, Y., Facer, P., Durrenberger, P., Chessell, I. P., Naylor, A., Bountra, C., Banati, R. R., & Anand, P. (2006) · BMC Neurology · doi:10.1186/1471-2377-6-12 · Cited by 509
Cabral, G. A., & Griffin-Thomas, L. (2009) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399409000957 · Cited by 408
Metadata
- Authors
- Croxford, J. L., & Miller, S. D.
- Venue
- Journal of Clinical Investigation
- Published
- 2003-04-15
- Volume
- 111
- Issue
- 8
- Pages
- 1231-1240
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2097503043
- Cited by
- 196
- References
- 5
- FWCI
- 11.64
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Immunoregulation of a viral model of multiple sclerosis using the synthetic cannabinoid R(+)WIN55,212. https://app.cochat.ai/papers/10.1172/jci17652
- The paper
- Croxford, J. L., & Miller, S. D. (2003). Immunoregulation of a viral model of multiple sclerosis using the synthetic cannabinoid R(+)WIN55,212. Journal of Clinical Investigation. https://doi.org/10.1172/jci17652
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.